BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Sep 27, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Lantus insulin glargine endocrine data

A pooled analysis of 2,171 Type II diabetics from 11 randomized clinical trials of Lantus given with or without oral diabetes drugs showed that Lantus in combination with 0 or 1 oral...

Read the full 139 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >